ESCALADE INC 10-K

ITEM 9A — CONTROLS AND PROCEDURES Evaluation of Disclosure Controls and Procedures Escalade maintains disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were not effective because of the material weakness in internal control over financial reporting described below in Management’s Report on Internal Control over Financial Reporting. See also, “Risk Factors – Legal, Tax, Accounting and Regulatory Risks.” Management ’ s Report on Internal Control over Financial Reporting Escalade’s management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Escalade’s internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting of the Company includes those policies and procedures that: (1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and 27 (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the Company’s financial statements. All internal control systems, no matter how well designed, have inherent limitations, including the possibility of human error or circumvention through collusion or improper overriding of controls. Therefore, even those internal control systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation. Further, because of changes in conditions, the effectiveness of internal control may vary over time. The management of Escalade assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2024. In making its assessment of internal control over financial reporting, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control – Integrated Framework (published in 2013) and implemented a process to monitor and assess both the design and operating effectiveness of the Company’s internal control. A material weakness is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected. In connection with the preparation of the Company’s financial statements for the year ended December 31, 2024, management identified a continued material weakness in the Company’s internal control over financial reporting as described below. Segregation of Duties Conflicts Material Weakness As previously reported in Part II, Item 9A. “Controls and Procedures” of our Annual Report on Form 10-K for the year ended December 31, 2023, among other material weaknesses, we identified a material weakness in our internal control over financial reporting related to controls over the period end close process involving segregation of duties conflicts. During the year ended December 31, 2024, certain material estimates / calculations continued to be prepared or compiled by the CFO. Because of this individual being the CFO there is not an individual in a supervisory role reviewing these estimates and calculations. Accordingly, this represents a continued material weakness in our controls over the period end close process involving segregation of duties conflicts. Although all other material weaknesses reported in the prior year have been remediated, management believes that, as of December 31, 2024, the Company’s internal control over financial reporting remains not effective due to this continued issue. We have also concluded this material weakness did not result in any material misstatements in our financial statements or disclosures in any of the years ended December 31, 2024 or 2023. This annual report on Form 10-K includes an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report regarding internal control over financial reporting is subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission. In addition, this report by management regarding internal control over financial reporting is specifically not incorporated by reference into any other filing by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. Our independent auditor, Grant Thornton LLP (“Grant Thornton”), a registered public accounting firm, is appointed by the Audit Committee of our Board of Directors. As a result of the material weakness described above, Grant Thornton has issued an adverse opinion on the effectiveness of our internal control over financial reporting as of December 31, 2024, which appears in Item 8. Financial Statements and Supplementary Data of this 2024 Form 10-K. Remediation Plan and Status The Company’s management and the Company’s Audit Committee are committed to achieving and maintaining a strong internal control environment. The Company’s management, with the Audit Committee’s oversight, is actively engaged in the planning for, and implementation of, remediation efforts to address the above described material weakness. 28 In response to the material weakness discussed above, we plan to continue efforts already underway to remediate internal control over financial reporting, including the following: ● We are in the process of redistributing the work previously performed by the CFO so that these material estimates and calculations will be performed by others within the accounting team and then reviewed and approved by the CFO. ● We are in the process of documenting and executing remediation action items, including expansion of mitigating controls where appropriate. Remediation of Previously Reported Material Weaknesses As previously reported in Part II, Item 9A. “Controls and Procedures” of our Annual Report on Form 10-K for the year ended December 31, 2023, in connection with our assessment of the effectiveness of internal control over financial reporting as of December 31, 2023, we identified control deficiencies relating to: ● Information technology general controls particularly as such controls related to user access, program change management, and ineffective complementary user-organization controls, which limited management’s ability to rely on technology dependent controls relevant to the preparation of the Company’s consolidated financial statements. ● Controls over the period end process, including the review and approval process of journal entries, account reconciliations, segregation of duties conflicts, and consolidation of intercompany entries. ● Documentation and design of controls related to various key financial statement accounts and assertions. ● The risk assessment, control activities, information and communication, and monitoring components of the Company’s internal control framework such that internal control weaknesses were not detected, communicated, addressed with mitigating control activities, or remediated. Other than described above with respect to segregation of duties conflicts, we have completed execution of our remediation plans for these material weaknesses and, as of December 31, 2024, successfully remediated these material weaknesses by implementing the following: ● Enhanced the design and documentation of our controls to evidence the existence of our controls, including our information technology general controls, risk assessment, information and communication, monitoring activities; ● Performed a risk assessment over the IT systems used as part of financial reporting and business processes, including various layers of technology; ● Implemented additional review and reconciliation controls to support the period end financial reporting process; and ● Hired an internal audit resource to effectively implement additional review, monitoring, and risk assessment. Management and our Audit Committee will continue to monitor these specific remedial measures and the effectiveness of our overall control environment. The identified material weakness in internal control over financial reporting will only be considered remediated when the relevant controls have operated effectively for a sufficient period of time for management to conclude that it has been remediated. We can provide no assurance as to when the remediation of this material weakness will be completed to provide for an effective control environment. /s/ Walter P. Glazer, Jr., Chief Executive Officer /s/ Stephen R. Wawrin, Chief Financial Officer 29 Changes in Internal Control over Financial Reporting Other than the completed and ongoing remediation efforts described above, management’s evaluation did not identify any changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended December 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. ITEM 9B — OTHER INFORMATION None . ITEM 9C — DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. Not applicable. Part III ITEM 10 — DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE Information required under this item with respect to Directors and Executive Officers is contained in the registrant's Proxy Statement relating to its annual meeting of stockholders scheduled to be held on May 6, 2025 under the captions “Certain Beneficial Owners,” “Election of Directors,” “Executive Officers of the Registrant,” “Board of Directors, Its Committees, Meetings and Functions,” and “Delinquent Section 16(a) Reports,” and is incorporated herein by reference. The Company’s Board of Directors has adopted the Escalade, Incorporated Code of Business Conduct and Ethics (“Code”) which may be found on the Company’s website at: www.escaladeinc.com/Code_of_Conduct.html . All employees, including executive officers, and directors of the Company, are subject to compliance with the Code. In addition, any future amendments to, or waivers from, a provision of Escalade’s Code of Business Conduct and Ethics that applies to Escalade’s directors or executive officers (including Escalade’s principal executive officer, principal financial officer, and principal accounting officer or controller) will be posted at this internet address. ITEM 11 — EXECUTIVE COMPENSATION Information required under this item is contained in the registrant's Proxy Statement relating to its annual meeting of stockholders scheduled to be held on May 6, 2025 under the captions “Compensation Discussion and Analysis,” “Compensation Committee Interlocks and Insider Participation,” “Report of the Compensation Committee” and “Executive Compensation” and is incorporated herein by reference, except that the information required by Item 407(e)(5) of Regulation S-K which appears under the caption “Report of the Compensation Committee” is specifically not incorporated by reference into this Form 10-K or into any other filing by the registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934. 30 ITEM 12 — SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS Except for the information required by Item 201(d) of Regulation S-K, which is included below, information required by this item is contained in the registrant’s proxy statement relating to its annual meeting of stockholders scheduled to be held on May 6, 2025 under the captions “Certain Beneficial Owners” and “Election of Directors” and is incorporated herein by reference. Equity Compensation Plan Information Plan Category Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights (2) Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans Equity compensation plans approved by security holders (1) - - 658,273 Equity compensation plans not approved by security holders - - - Total - 658,273 (1) The maximum number of shares that can be awarded under the Escalade, Incorporated 2017 Incentive Plan is 1,661,598. The plan was approved by stockholders at Escalade’s Annual Meetings of Stockholders in 2017. (2) Does not include 307,322 shares subject to outstanding, unvested restricted stock unit awards. ITEM 13 — CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE The information required by Item 407(a) of Regulation S-K is contained in the registrant’s proxy statement relating to its annual meeting of stockholders to be held on May 6, 2025 under the captions “Election of Directors” and “Board of Directors, Its Committees, Meetings and Functions” and is incorporated herein by reference. The information required by Item 404 of Regulation S-K is contained in the registrant’s proxy statement relating to its annual meeting of stockholders scheduled to be held on May 6, 2025 under the caption “Certain Relationships and Related Person Transactions” and is incorporated herein by reference. ITEM 14 — PRINCIPAL ACCOUNTING FEES AND SERVICES The Company’s independent registered accounting firm is Grant Thornton, LLP; St. Louis, MO; PCAOB ID: 248. The information required by this item is contained in the registrant’s proxy statement relating to its annual meeting of stockholders scheduled to be held on May 6, 2025 under the caption “Principal Accounting Firm Fees” and is incorporated herein by reference. 31 Part IV ITEM 15 — EXHIBITS, FINANCIAL STATEMENT SCHEDULES (A) Documents filed as a part of this report: (1) Financial Statement s Reports of Independent Registered Public Accounting Firm Consolidated financial statements of Escalade, Incorporated and subsidiaries: Consolidated balance sheets—December 31, 2024 and December 31, 2023 Consolidated statements of operations—fiscal years ended December 31, 2024 and December 31, 2023 Consolidated statements of stockholders’ equity—fiscal years ended December 31, 2024 and December 31, 2024 Consolidated statements of cash flows—fiscal years ended December 31, 2024 and December 31, 2023 Notes to consolidated financial statements All other schedules are omitted because of the absence of conditions under which they are required or because the required information is given in the consolidated financial statements or notes thereto. (3) Exhibits 3.1 Articles of Incorporation of Escalade, Incorporated. Incorporated by reference from Exhibit 3.1 to the Company’s 2007 First Quarter Report on Form 10-Q. 3.2 Amended By-Laws of Escalade, Incorporated. Incorporated by reference from Exhibit 3.2 to the Company’s 2022 Third Quarter Report on Form 10-Q filed on October 27, 2022. 4.1 Description of Escalade’s Registered Securities 10.1 Amended and Restated Credit Agreement dated as of January 21, 2022 among Escalade, Incorporated, Indian Industries, Inc., each of their domestic subsidiaries, and JPMorgan Chase Bank, N.A., as Administrative Agent (without exhibits and schedules, which Escalade has determined are not material). Incorporated by reference from Exhibit 10.2 to the Company’s Form 8-K filed on January 24, 2022. 10.2 Amended and Restated Pledge and Security Agreement dated as of January 21, 2022 among Escalade, Incorporated, Indian Industries, Inc., each of their domestic subsidiaries, and JPMorgan Chase Bank, N.A., as Administrative Agent (without exhibits and schedules, which Escalade has determined are not material). Incorporated by reference from Exhibit 10.3 to the Company’s Form 8-K filed on January 24, 2022. 10.3 First Amendment dated July 18, 2022 to the Amended and Restated Credit Agreement dated as of January 21, 2022 among Escalade, Incorporated, Indian Industries, Inc., each of their domestic subsidiaries, and JPMorgan Chase Bank, N.A., as Administrative Agent. Incorporated by reference from Exhibit 10.1 to the Company’s Form 8-K filed on July 21, 2022. 10.4 Second Amendment dated October 26, 2022 to the Amended and Restated Credit Agreement dated as of January 21, 2022 among Escalade, Incorporated, Indian Industries, Inc., each of their domestic subsidiaries, and JPMorgan Chase Bank, N.A., as Administrative Agent. Incorporated by reference from Exhibit 10.1 to the Company’s Form 8-K filed on October 27, 2022. 10.5 Third Amendment dated May 8, 2023 to the Amended and Restated Credit Agreement dated as of January 21, 2022 among Escalade, Incorporated, Indian Industries, Inc., each of their domestic subsidiaries, and JPMorgan Chase Bank, N.A., as Administrative Agent. Incorporated by reference from Exhibit 10.1 to the Company’s Form 8-K filed on May 9, 2023. 10.6 Fifth Amendment dated October 11, 2024 to the Amended and Restated Credit Agreement dated as of January 21, 2022 among Escalade, Incorporated, Indian Industries, Inc., each of their domestic subsidiaries, and JPMorgan Chase Bank, N.A., as Administrative Agent. Incorporated by reference from Exhibit 10.1 to the Company’s Form 8-K filed on October 15, 2024. 32 (4) Executive Compensation Plans and Arrangements 10.6 Escalade, Incorporated 2017 Incentive Plan. Incorporated by reference herein from Annex 1 to the Registrant’s 2017 Definitive Proxy Statement filed on March 28, 2017. 10.7 Form of Stock Option Award Agreement utilized in Stock Option grants to employees pursuant to the Escalade, Incorporated 2017 Incentive Plan. Incorporated by reference from Exhibit 10.8 to the Company’s Form 10-K for the fiscal year ended December 30, 2017 and filed on February 27, 2018. 10.8 Form of Stock Option Award Agreement utilized in Stock Option grants to Directors pursuant to the Escalade, Incorporated 2017 Incentive Plan. Incorporated by reference from Exhibit 10.9 to the Company’s Form 10-K for the fiscal year ended December 30, 2017 and filed on February 27, 2018. 10.9 Form of Restricted Stock Unit Agreement utilized in Restricted Stock Unit grants to employees pursuant to the Escalade Incorporated 2017 Incentive Plan. Incorporated by reference from Exhibit 10.10 to the Company’s Form 10-K for the fiscal year ended December 30, 2017 and filed on February 27, 2018. 10.10 Form of Restricted Stock Unit Agreement utilized in Restricted Stock Unit grants to Directors pursuant to the Escalade, Incorporated 2017 Incentive Plan. Incorporated by reference from Exhibit 10.11 to the Company’s Form 10-K for the fiscal year ended December 30, 2017 and filed on February 27, 2018. 19.1 Escalade, Incorporated Confidentiality of Insider Information and Securities Trades by Company Personnel. Incorporated by reference from Exhibit 19.1 to the Company’s Form 10-K for the fiscal year ended December 31, 2023 and filed on March 29, 2024. 21 Subsidiaries of the Registrant 23.1 Consent of FORVIS, LLP 23.2 Consent of Grant Thornton, LLP 31.1 Chief Executive Officer Rule 13a-14(a)/15d-14(a) Certification 31.2 Chief Financial Officer Rule 13a-14(a)/15d-14(a) Certification 32.1 Chief Executive Officer Section 1350 Certification 32.2 Chief Financial Officer Section 1350 Certification 97.1 Escalade, Incorporated Amended and Restated Policy for Recovery of Incentive Compensation. Incorporated by reference from Exhibit 97.1 to the Company’s Form 10-K for the fiscal year ended December 31, 2023 and filed on March 29, 2024. 99.1 Fourth Amendment effective as of September 1, 2023 to the Amended and Restated Credit Agreement dated as of January 21, 2022 among Escalade, Incorporated, Indian Industries, Inc., each of their domestic subsidiaries, and JPMorgan Chase Bank, N.A., as Administrative Agent (which Amendment Escalade has determined did not contain any material new or amended terms). Incorporated by reference from Exhibit 99.1 to the Company’s 2023 Third Quarter Report on Form 10-Q filed on October 26, 2023. 101.Cal Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.Def Inline XBRL Taxonomy Extension Definition Linkbase Document 101.Lab Inline XBRL Taxonomy Extension Label Linkbase Document 101.Pre Inline XBRL Taxonomy Extension Presentation Linkbase Document 101.Ins Inline XBRL Instance Document 101.Sch Inline XBRL Taxonomy Extension Schema Document 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) ITEM 16 — FORM 10-K SUMMARY None. 33 Escalade, Incorporated and Subsidiaries Index to Financial Statements The following consolidated financial statements of the Registrant and its subsidiaries and Independent Accountants’ Reports are submitted herewith: Page Reports of Independent Registered Public Accounting Firm (Grant Thornton LLP, PCAOB ID number 248 ) 35 Report of Independent Registered Public Accounting Firm (FORVIS LLP, PCAOB ID number 686) 39 Consolidated financial statements of Escalade, Incorporated and subsidiaries: Consolidated balance sheets—December 31, 2024 and December 31, 2023 40 Consolidated statements of operations—fiscal years ended December 31, 2024 and December 31, 2023 41 Consolidated statements of stockholders’ equity—fiscal years ended December 31, 2024 and December 31, 2023 42 Consolidated statements of cash flows—fiscal years ended December 31, 2024 and December 31, 2023 43 Notes to consolidated financial statements 44 34 Report of Independent Registered Public Accounting Firm Board of Directors and Shareholders Escalade, Incorporated Opinion on the financial statements We have audited the accompanying consolidated balance sheet of Escalade, Incorporated (an Indiana corporation) and subsidiaries (the “Company”) as of December 31, 2024, the related consolidated statements of operations, stockholders’ equity, and cash flows for the year ended December 31, 2024, and the related notes, collectively referred to as the consolidated financial statements. In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows for the year ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company’s internal control over financial reporting as of December 31, 2024, based on criteria established in the 2013 Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), and our report dated March 10, 2025 expressed an adverse opinion. We also have audited the adjustments to the 2023 information in Note 11 to retrospectively apply the change in accounting (resulting from the adoption of Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ), as described in Note 1. In our opinion, such adjustments are appropriate and have been properly applied. We were not engaged to audit, review, or apply any procedures to the 2023 financial statements of the Company other than with respect to such adjustments and, accordingly, we do not express an opinion or any other form of assurance on the 2023 financial statements taken as a whole. Basis for opinion These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion. Critical audit matter The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates. 35 Goodwill impairment assessment for the Escalade Sports reporting unit As described further in Note 1 and Note 5 to the consolidated financial statements, the goodwill balance as of December 31, 2024, was $42.3 million, of which all of that balance was allocated to the Escalade Sports reporting unit. The Company reviews goodwill for impairment annually and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. The Company estimates the fair value of the Escalade Sports reporting unit by using a combination of the income and market approaches to perform the impairment assessment. We identified the determination of the Escalade Sports reporting unit’s fair value used in the goodwill impairment assessment as a critical audit matter. The audit of the fair value and the related assumptions required a high degree of auditor judgment, including the need to involve our fair value specialists when testing the reasonableness of the models and methodologies used by management. Additionally, the fair value estimate contained highly judgmental and significant assumptions such as the revenue projections, assumed gross profit margins, and the assumed EBITDA margins. Our audit procedures related to the goodwill impairment assessment for the Escalade Sports reporting unit included the following, among others. ● We tested the effectiveness of internal controls over the goodwill impairment analysis, including those over the inputs and assumptions used in the projections. ● We evaluated the reasonableness of management’s projections by comparing the projections to historical financial results, independent estimates, and industry reports. ● We performed sensitivity analyses of certain significant assumptions to evaluate the changes in fair value that would result from changes in the growth rate and EBITDA margin assumptions with the assistance of our fair value specialists. ● We evaluated the reasonableness of the valuation methodologies, certain assumptions used within the models, and tested the mathematical accuracy of the valuation models with the assistance of our fair value specialists. GRANT THORNTON LLP /s/ GRANT THORNTON LLP We have served as the Company’s auditor since 2024. St. Louis, Missouri March 10, 2025 36 Report of Independent Registered Public Accounting Firm Board of Directors and Shareholders Escalade, Incorporated Opinion on internal control over financial reporting We have audited the internal control over financial reporting of Escalade, Incorporated (an Indiana corporation) and subsidiaries (the “Company”) as of December 31, 2024, based on criteria established in the 2013 Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). In our opinion, because of the effect of the material weakness described in the following paragraphs on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December 31, 2024, based on criteria established in the 2013 Internal Control — Integrated Framework issued by COSO. A material weakness is a deficiency, or combination of control deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weakness has been identified and included in management’s assessment. There were certain material estimates/calculations that were prepared or compiled by the CFO. Because of this individual being the CFO there is not an individual in a supervisory role reviewing these. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the consolidated financial statements of the Company as of and for the year ended December 31, 2024. The material weakness identified above was considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2024 consolidated financial statements, and this report does not affect our report dated March 10, 2025, which expressed an unqualified opinion on those financial statements. Basis for opinion The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. Definitions and limitations of internal control over financial reporting A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements. 37 Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. GRANT THORNTON LLP /s/ GRANT THORNTON LLP St. Louis, Missouri March 10, 2025 38 Report of Independent Registered Public Accounting Firm To the Shareholders, Board of Directors, and Audit Committee Escalade, Incorporated Opinion on the Consolidated Financial Statement We have audited, before the effects of the adjustments to retrospectively apply the change in accounting (as described in Notes 1 and 11) and the disclosure of “Net sales by geographic region/country” (as described in Note 11), the accompanying consolidated balance sheet of Escalade, Incorporated (the “Company”) as of December 31, 2023, and the related consolidated statements of operations, stockholders’ equity and cash flows for the year ended December 31, 2023, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements referred to above, before the effects of the adjustments to retrospectively apply the change in accounting (as described in Notes 1 and 11) and disclosure of “Net sales by geographic region/country” (as described in Note 11), present fairly, in all material respects, the consolidated financial position of Escalade, Incorporated as of December 31, 2023, and the results of its operations and its cash flows for the year ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America. We were not engaged to audit, review, or apply any procedures to the adjustments to retrospectively apply the change in accounting (as described in Notes 1 and 11) and disclosure of “Net sales by geographic region/country” (described in Note 11) and, accordingly, we do not express an opinion or any other form of assurance about whether such adjustments are appropriate and have been properly applied. Those adjustments were audited by Grant Thornton, LLP. Basis for Opinion These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion. /s/ FORVIS, LLP We have served as Escalade, Incorporated’s auditor from 1977 to 2024. Tysons, VA March 29, 2024 39 Escalade, Incorporated and Subsidiaries Consolidated Balance Sheets All Amounts in Thousands Except Share Information December 31, 2024 December 31, 2023 ASSETS Current Assets: Cash and cash equivalents $ 4,194 $ 16 Receivables, less allowance for credit losses of $ 694 and $ 652 ; respectively 48,768 49,985 Inventories 76,025 92,462 Prepaid expenses 4,372 4,280 Prepaid income tax 465 88 TOTAL CURRENT ASSETS 133,824 146,831 Property, plant and equipment, net 22,221 23,786 Assets held for sale - 2,653 Operating lease right-of-use assets 1,186 8,378 Intangible assets, net 25,838 28,640 Goodwill 42,326 42,326 Other assets 935 391 TOTAL ASSETS $ 226,330 $ 253,005 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of long-term debt $ 7,143 $ 7,143 Trade accounts payable 11,858 9,797 Accrued liabilities 15,050 15,283 Current operating lease liabilities 444 1,041 TOTAL CURRENT LIABILITIES 34,495 33,264 Long-term debt 18,452 43,753 Deferred income tax liability, net 3,302 3,125 Operating lease liabilities 787 7,897 Other liabilities 297 387 TOTAL LIABILITIES 57,333 88,426 Commitments and contingencies - - Stockholders' equity: Preferred stock Authorized: 1,000,000 shares, no par value, none issued - - Common stock Authorized: 30,000,000 shares, no par value Issued and outstanding: 2024 — 13,732,719 shares, 2023 — 13,736,800 shares 4,218 4,480 Retained earnings 164,779 160,099 TOTAL STOCKHOLDERS’ EQUITY 168,997 164,579 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 226,330 $ 253,005 See notes to consolidated financial statements. 40 Escalade, Incorporated and Subsidiaries Consolidated Statements of Operations Years Ended All Amounts in Thousands Except Per Share Data December 31, 2024 December 31, 2023 Net Sales $ 251,510 $ 263,566 Costs and Expenses Cost of products sold 189,306 201,795 Selling, administrative and general expenses 43,303 41,480 Amortization 2,802 2,480 Gain on sale of assets held for sale ( 3,905 ) - Operating Income 20,004 17,811 Other Income (Expense) Interest expense ( 2,302 ) ( 5,349 ) Other income (expense) 74 31 Income Before Income Taxes 17,776 12,493 Provision for Income Taxes 4,790 2,664 Net Income $ 12,986 $ 9,829 Earnings Per Share Data: Basic earnings per share $ 0.94 $ 0.72 Diluted earnings per share $ 0.93 $ 0.71 See notes to consolidated financial statements. 41 Escalade, Incorporated and Subsidiaries Consolidated Statements of Stockholders ’ Equity Common Stock Retained All Amounts in Thousands Shares Amount Earnings Total Balances at December 31, 2022 13,594 $ 2,025 $ 156,450 $ 158,475 Net income - - 9,829 9,829 Expense of restricted stock units - 2,008 - 2,008 Settlement of restricted stock units 108 - - - Dividends declared - - ( 6,180 ) ( 6,180 ) Stock issued to directors as compensation 4 52 - 52 Issuance of common stock for service 31 395 - 395 Balances at December 31, 2023 13,737 $ 4,480 $ 160,099 $ 164,579 Net income - - 12,986 12,986 Expense of restricted stock units - 1,932 - 1,932 Settlement of restricted stock units 140 - - - Dividends declared - - ( 8,306 ) ( 8,306 ) Purchase of stock ( 144 ) ( 2,194 ) - ( 2,194 ) Balances at December 31, 2024 13,733 $ 4,218 $ 164,779 $ 168,997 See notes to consolidated financial statements. 42 Escalade, Incorporated and Subsidiaries Consolidated Statements of Cash Flows Years Ended All Amounts in Thousands December 31, 2024 December 31, 2023 Operating Activities: Net Income $ 12,986 $ 9,829 Reconciling adjustments: Depreciation and amortization 6,041 5,671 Allowance for credit losses 747 566 Stock option and restricted stock unit expense 1,932 2,008 Common stock issued in lieu of bonus to officers - 395 Director stock compensation - 52 Deferred income taxes 177 ( 1,391 ) Gain on disposals of assets ( 3,651 ) ( 111 ) Changes in Accounts receivable 470 6,867 Inventories 16,437 29,409 Prepaids and other assets ( 1,724 ) 752 Accounts payable and accrued expenses 2,634 ( 5,719 ) Net cash provided by operating activities 36,049 48,328 Investing Activities: Purchase of property and equipment ( 2,038 ) ( 2,085 ) Proceeds from sale of property and equipment 5,967 140 Net cash provided by (used in) investing activities 3,929 ( 1,945 ) Financing Activities: Dividends paid ( 8,306 ) ( 6,180 ) Proceeds from issuance of long-term debt 114,785 93,998 Payments on long-term debt ( 140,085 ) ( 137,983 ) Deferred financing fees - ( 169 ) Purchase of stock ( 2,194 ) - Net cash used in financing activities ( 35,800 ) ( 50,334 ) Increase (decrease) in Cash and Cash Equivalents 4,178 ( 3,951 ) Cash and Cash Equivalents, beginning of year 16 3,967 Cash and Cash Equivalents, end of year $ 4,194 $ 16 Supplemental Cash Flows Information Interest paid $ 2,231 $ 5,330 Income taxes paid, net $ 4,989 $ 4,260 See notes to consolidated financial statements. 43 Note 1 — Nature of Operations and Summary of Significant Accounting Policies Nature of Operations Escalade, Incorporated and its wholly-owned subsidiaries (Escalade, the Company, we, us or our) are engaged in the manufacture and sale of sporting goods products. The Company is headquartered in Evansville, Indiana and currently has manufacturing facilities in the United States of America. The Company imports many of its raw materials and finished goods from countries outside of the United States, including but not limited to China, Brazil, Vietnam and Mexico. The Company sells products to customers primarily in North America with minimal sales throughout the remainder of the world. Principles of Consolidation The consolidated financial statements include the accounts of Escalade, Incorporated and its wholly-owned subsidiaries. All material inter-company accounts and transactions have been eliminated. Basis of Presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The books and records of subsidiaries located in foreign countries are maintained according to generally accepted accounting principles in those countries. Upon consolidation, the Company evaluates the differences in accounting principles and determines whether adjustments are necessary to convert the foreign financial statements to the accounting principles upon which the consolidated financial statements are based. As a result of this evaluation no material adjustments were identified. Cash and Cash Equivalents Highly liquid financial instruments with insignificant interest rate risk and with original maturities of three months or less are classified as cash and cash equivalents. Cash and cash equivalent balances may at times be in excess of federally insured limits. The Company maintains its cash and cash equivalent balances at high-credit quality financial institutions. Book overdrafts that result from outstanding checks in excess of our bank balance are reclassified to accrued liabilities. As of December 31, 2024, the Company reclassed $ 0.1 million of book overdrafts to accrued liabilities. As of December 31, 2023, the Company reclassed $ 3.4 million of book overdrafts to accrued liabilities. Accounts Receivable Revenue from the sale of the Company’s products is recognized when obligations under the terms of a contract with our customer are satisfied; generally this occurs with the transfer of control of our goods at a point in time based on shipping terms and transfer of title. Accounts receivables are stated at the amount billed to customers, net of the allowance for credit losses and accrued discounts. Interest and late charges billed to customers are not material and, because collection is uncertain, are not recognized until collected and are therefore not included in accounts receivable. The Company provides an allowance for credit losses which is described in Note 2 – Certain Significant Estimates. Inventories We value inventories at the lower of cost (first-in, first-out) or net realizable value. We regularly review inventories for excess quantities and obsolescence based upon historical experience, specific identification of discontinued items, future demand, and market conditions. Work in process and finished goods inventory are determined to be saleable based on a demand forecast within a specific time horizon, generally one year or less. Inventories at fiscal year-ends were as follows: In Thousands 2024 2023 Raw materials $ 2,721 $ 4,050 Work in process 2,370 2,308 Finished goods 70,934 86,104 $ 76,025 $ 92,462 44 Property, Plant and Equipment Property, plant and equipment are recorded at cost. Depreciation and amortization are computed for financial reporting purposes principally using the straight-line method over the following estimated useful lives: buildings, 20 - 30 years; leasehold improvements, term of the lease; machinery and equipment, 5 - 15 years; and tooling, dies and molds, 2 - 5 years. Property, plant and equipment consist of the following: In Thousands 2024 2023 Land $ 1,306 $ 1,306 Buildings and leasehold improvements 28,954 28,207 Machinery and equipment 27,616 29,194 Total cost 57,876 58,707 Accumulated depreciation and amortization ( 35,655 ) ( 34,921 ) $ 22,221 $ 23,786 Depreciation expenses relating to property, plant and equipment for the years ended December 31, 2024 and 2023 were $ 3.2 million and $ 3.2 million, respectively. The Company evaluates the recoverability of certain long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Estimates of future cash flows used to test recoverability of long-lived assets include separately identifiable undiscounted cash flows expected to arise from the use and eventual disposition of the assets. Where estimated future cash flows are less than the carrying value of the assets, impairment losses are recognized based on the amount by which the carrying value exceeds the fair value of the assets. No asset impairment was recognized during the years ended 2024 or 2023. We classify assets as held for sale when our management approves and commits to a formal plan of sale that is probable of being completed within one (1) year. Assets designated as held for sale are recorded at the lower of their current carrying value or their fair market value, less costs to sell, beginning in the period in which the assets meet the criteria to be classified as held for sale. During 2024, the Company completed the sale of its Mexico facility for $ 6.6 million. The Company received cash proceeds of $ 5.9 million, with the remaining $ 0.7 million deposited in an escrow account. The Company recognized a gain of $ 3.9 million, included in operating income in the Consolidated Statement of Operations. Goodwill and Intangible Assets Goodwill represents the excess of the purchase price over fair value of net tangible and identifiable intangible assets of acquired businesses. Intangible assets consist of patents, consulting agreements, non-compete agreements, customer lists, developed technology, license agreements, and trade names. Goodwill is deemed to have an indefinite life and is not amortized. Other intangible assets are amortized using the straight-line method over the following lives: license agreements, 17 years; developed technology, 5 years; trade names, 20 years to indefinite life; consulting agreements, the life of the agreement; customer lists, 3 to 15 years; non-compete agreements, the lesser of the term or 5 years; and patents, the lesser of the remaining life or 5 to 15 years. 45 The Company reviews goodwill and other indefinite lived intangibles for impairment annually and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable, in accordance with guidance in FASB ASC 350, Intangibles – Goodwill and Other . If we determine that the carrying value of the indefinite lived intangible is greater than the fair value, we record a permanent impairment charge for the amount by which the carrying value exceeds its fair value. We measure the fair value of our reporting unit based on a guideline company method and discounted cash flow method using a discount rate determined by Management to be commensurate with the risk inherent in our reporting unit's current business model. The fair market value was determined by weighting the two methods equally. Management performed a quantitative impairment analysis as of November 1, 2024 for goodwill, which included a detailed calculation of the fair value of our reporting unit. A Step 0 analysis was performed for 2023. Additionally, a Step 0 analysis was performed during 2024 and 2023 for our indefinite lived trade names. The results of these impairment analyses indicated that the fair values of the trade names and reporting unit are not less than their carrying values. Our estimates of discounted cash flows, selected multiples and market value of invested capital to derive the fair value were measured in accordance with ASC 350, Intangibles – Goodwill and Other . Inputs to determine the fair value are considered to be level 3 inputs. We are using estimates of discounted cash flows that may change, and if they change negatively it could result in the need to write down those assets to fair value. Employee Incentive Plan During 2017, the Company approved an incentive plan explained in Note 9. The Company accounts for this plan under the recognition and measurement principles of FASB ASC 718, Equity Based Payments . Debt Issuance Costs Costs incurred with the issuance of the Company’s senior revolving credit facility have been deferred and amortized over the term of the facility as a component of interest expense using the straight-line method. These deferred costs are included in other assets in the consolidated balance sheets. Foreign Currency The functional currency for the foreign operations of Escalade is the U.S. dollar. Gains or losses resulting from foreign currency transactions are included in selling, general and administrative expense in the Consolidated Statements of Operations and were insignificant in fiscal years 2024 and 2023. Cost of Products Sold Cost of products sold is comprised of those costs directly associated with or allocated to the products sold and include materials, labor and factory overhead. Research and Development Research and development costs are charged to expense as incurred. Research and development costs incurred during 2024 and 2023 were approximately $ 3.2 million and $ 3.1 million, respectively. Selling, General and Administrative Expense Selling, general and administrative expenses include personnel-related costs, including stock-based compensation, selling, advertising, and other general operating expenses. Advertising costs are expensed in the period incurred. Total advertising expenses incurred during 2024 and 2023 were approximately $ 7.2 million and $ 6.9 million, respectively. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax assets may be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are regularly reviewed for realizability, and a valuation allowance is established when the Company believes it is more likely than not the tax benefit of such assets will not be realized, taking into consideration historical operating results, expectations of future earnings, tax planning strategies, and the expected timing of the reversals of existing temporary differences. 46 The benefits of uncertain tax positions are recorded in the Company’s financial statements only after determining a more likely than not probability that the uncertain tax positions will withstand challenge, if any, from taxing authorities. When facts and circumstances change, the Company reassesses these probabilities and records any changes through the provision for income taxes. The Company recognizes interest and penalties relating to uncertain tax provisions as a component of interest expense and selling, general and administrative costs, respectively in the Company’s financial statements. New Accounting Pronouncements and Changes in Accounting Principles Standards Adopted: In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which enhances reporting requirements under Topic 280. ASU 2023-07 requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within the segment measure of profit or loss, an amount and description of its composition for other segment items to reconcile to segment profit or loss, and the title and position of the entity’s CODM. The Company adopted ASU 2023-07 during the year ended December 31, 2024. As a result, we have enhanced our segment disclosures to include the disclosure of our CODM. The adoption of this ASU affects only our disclosures, with no impact to our financial condition and results of operation. New Accounting Standards to be Adopted In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This amendment requires entities to provide additional information in the income tax rate reconciliation and additional disclosures about income taxes paid. The amendment requires entities to disclose in their rate reconciliation table additional categories of information about federal, state and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The amendment is effective for annual periods beginning after December 15, 2024, and should be applied prospectively, but entities have the option to apply it retrospectively for each period presented. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company is in the process of evaluating the impact of the new standard on the related disclosures. In November 2024, the FASB issued ASU 2024.03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This amendment requires additional disclosures of certain costs and expenses within the notes to the financial statements. The updated standard is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is in the process of evaluating the impact that the updated standard will have on our financial statement disclosures. Note 2 — Certain Significant Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities; the disclosure of contingent assets and liabilities at the date of the consolidated financial statements; and the reported amounts of revenues and expenses during the reporting period. These estimates and judgments are evaluated on an ongoing basis and are based on experience; current and expected future conditions; third party evaluations; and various other assumptions believed reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities as well as identifying and assessing the accounting treatment with respect to commitments and liabilities. Actual results may differ from the estimates and assumptions used in the financial statements and related notes. Listed below are certain significant estimates and assumptions related to the preparation of the consolidated financial statements: 47 Product Warranty The Company provides limited warranties on certain of its products, for varying periods. Generally, the warranty periods range from 30 days to one year. However, some products carry extended warranties of three -year, five -year, seven -year, ten -year, fifteen -year, and lifetime warranties. The Company records an accrued liability and reduction in sales for estimated future warranty claims based upon historical experience and management’s estimate of the level of future claims. Changes in the estimated amounts recognized in prior years are recorded as an adjustment to the accrued liabilities and sales in the current year. Changes in product warranty were as follows: In Thousands 2024 2023 Beginning balance $ 590 $ 1,013 Additions 1,690 528 Deductions ( 1,631 ) ( 951 ) Ending balance $ 649 $ 590 Allowance for Credit Losses The Company provides an allowance for credit losses based upon a review of outstanding receivables, historical collection experience and financial condition of the customer. Accounts receivables are ordinarily due between 30 and 60 days after the issuance of the invoice. Changes in allowance for credit losses were as follows: In Thousands 2024 2023 Beginning balance $ 652 $ 492 Additions 747 566 Deductions ( 705 ) ( 406 ) Ending balance $ 694 $ 652 Note 3 — Accrued Liabilities Accrued liabilities consist of the following: In Thousands 2024 2023 Employee compensation $ 4,635 $ 2,653 Customer co-op and volume allowances 1,543 1,671 Customer return accruals and other allowances 5,165 3,654 Other accrued items 3,707 7,305 $ 15,050 $ 15,283 Note 4 — Leases We have operating leases for office, manufacturing and distribution facilities as well as for certain equipment. Our leases have remaining lease terms of 1 year to 4 years. As of December 31, 2024, the Company has not entered into any lease arrangements classified as a finance lease. We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities and operating lease liabilities on our consolidated balance sheet. The Company has elected an accounting policy to not recognize short-term leases (total expected use of one year or less) on the balance sheet. The Company also elected the package of practical expedients which applies to leases that commenced before the adoption date. By electing the package of practical expedients, the Company did not need to reassess the following: whether any existing contracts are or contain leases, the lease classification for any existing leases and initial direct costs for any existing leases. 48 ROU assets and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. When the implicit rate of the lease is not provided or cannot be determined, we use our incremental borrowing rate based on the information available at the commencement date to determine the present value of future payments. Lease terms may include options to extend or terminate the lease and are factored into the ROU asset/liability when it is reasonably certain that we will exercise those options. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. On December 31, 2024, the Company terminated its long-term lease for its facility in Orlando, FL. The initial expiration date of the lease was January 2033. The removal of the related ROU asset and lease liability created a non-cash gain of $ 522 thousand. As part of the termination agreement, the Company received a payment of $ 500 thousand from the lessor. This coupled with the removal of the ROU asset and lease liability, offset by related expenses to settle the lease, resulted in a net gain on lease termination of $ 685 thousand, recorded as a reduction to cost of products sold in the consolidated statement of operations. The $ 500 thousand payment received is netted against operating lease operating cash flows below. Components of lease expense and other information are as follows: All Amounts in Thousands Twelve Months Ended December 31, 2024 Twelve Months Ended December 31, 2023 Lease Expense Operating Lease Cost $ 1,341 $ 1,522 Short-term Lease Cost 1,228 1,998 Variable Lease Cost 529 464 Gain on Lease Termination ( 685 ) - Total Operating Lease Cost $ 2,413 $ 3,984 Operating Lease – Operating Cash Flows $ 991 $ 1,020 New ROU Assets/Liabilities – Operating Leases (non-cash) $ 52 $ 325 Other information about lease amounts recognized in our consolidated financial statements is summarized as follows: Period Ended December 31, 2024 Period Ended December 31, 2023 Weighted Average Remaining Lease Term – Operating Leases (in years) 2.84 8.09 Weighted Average Discount Rate – Operating Leases 6.23 % 5.20 % Future minimum lease payments under non-cancellable leases as of December 31, 2024 were as follows: All Amounts in Thousands 2025 $ 506 2026 442 2027 334 2028 65 2029 - Thereafter - Total future minimum lease payments 1,347 Less imputed interest ( 116 ) Total $ 1,231 49 Note 5 — Acquired Intangible Assets and Goodwill The carrying basis and accumulated amortization of recognized intangible assets are summarized in the following table: 2024 2023 In Thousands Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Patents 24,715 24,533 24,715 24,410 Non-compete agreements 2,749 2,749 2,749 2,749 Customer list 22,017 13,122 22,017 11,466 Trade names 18,636 1,875 18,636 1,339 Developed technology 475 475 475 475 License agreements 700 700 700 213 69,292 43,454 69,292 40,652 Amortization expense was $ 2.8 million and $ 2.5 million for 2024 and 2023, respectively. At December 31, 2024, the net carrying amount of trade names includes $ 7.8 million related to indefinite-lived intangible assets which are not amortized but are evaluated for impairment at least annually. Estimated future amortization expense is summarized in the following table: All Amounts in Thousands 2025 $ 2,265 2026 2,218 2027 2,132 2028 1,482 2029 1,374 Thereafter 8,583 Subtotal 18,054 Indefinite-lived intangible asset balance 7,784 Total $ 25,838 Consistent with our operating segment conclusion, we have concluded one reporting unit exists and all goodwill and indefinite lived intangibles are allocated to that reporting unit. There were no changes to the carrying amount of goodwill in 2024 or 2023. Note 6 — Borrowings On January 21, 2022, the Company and its wholly owned subsidiary, Indian Industries, Inc. (“Indian”), entered into an Amended and Restated Credit Agreement (“2022 Restated Credit Agreement”) with its issuing bank, JP Morgan Chase Bank, N.A. (“Chase”), and the other lenders identified in the 2022 Restated Credit Agreement (collectively, the “Lenders”). Under the terms of the 2022 Restated Credit Agreement, Old National Bank was added as a Lender. The Lenders made available to the Company a senior revolving credit facility with increased maximum availability of $ 65.0 million (the “Revolving Facility”), up from $ 50.0 million, plus an accordion feature that would allow borrowings up to $ 90.0 million under the Revolving Facility subject to certain terms and conditions. The maturity date of the revolving credit facility was extended to January 21, 2027. The Company may prepay the Revolving Facility, in whole or in part, and reborrow prior to the revolving loan maturity date. The Restated Credit Agreement further extended the maturity date for the term loan facility to January 21, 2027. 50 In addition to the increased borrowing amount and extended maturity date, the 2022 Restated Credit Agreement provided a $ 7.5 million swingline commitment by Chase, replaced LIBOR with the replacement benchmark secured overnight financing rate, and adjusted certain financial covenants relating to the fixed charge coverage ratio. On July 18, 2022, the Company entered into the First Amendment (the “First Amendment”) to the 2022 Restated Credit Agreement. Under the terms of the First Amendment, the Lenders increased the maximum availability under the senior revolving credit facility from $ 65.0 million to $ 75.0 million pursuant to the accordion feature in the 2022 Restated Credit Agreement. The First Amendment also adjusted the funded debt to EBITDA ratio financial covenant to 3:00 to 1:00 as of the end of the Company’s third and fourth fiscal quarters of 2022. On October 26, 2022, the Company entered into the Second Amendment (the “Second Amendment”) to the 2022 Restated Credit Agreement. Under the terms of the Second Amendment, the Lenders increased the maximum availability under the senior revolving credit facility from $ 75.0 million to $ 90.0 million pursuant to the accordion feature in the 2022 Restated Credit Agreement. The Second Amendment adjusted the funded debt to EBITDA ratio financial covenant to 3:25 to 1:00 as of the end of the Company’s third and fourth fiscal quarters of 2022 and 3 :00 to 1:00 as of the end of the Company’s first fiscal quarter of 2023. The Second Amendment also modified the EBITDA definition to permit add-backs of a) up to $ 2.0 million for disposition related expenses; and b) up to $ 2.0 million for unusual or non-recurring expenses which are incurred prior to the end of fiscal year 2023 and which are subject to the approval of the Administrative Agent. On May 8, 2023, the Company entered into the Third Amendment (the “Third Amendment”) to the Restated Credit Agreement. The Third Amendment adjusted the funded debt to EBITDA ratio financial covenant to 4:25 to 1:00 as of the end of the Company’s second fiscal quarter of 2023, 3:00 to 1:00 as of the end of the Company’s third fiscal quarter of 2023, and 2:75 to 1:00 as of the end of the Company’s fourth fiscal quarter of 2023 and thereafter. The Third Amendment adjusted the fixed charge coverage ratio covenant to 1:10 to 1:00 commencing as of the Company’s fourth fiscal quarter of 2023 and 1:25 to 1:00 as of the end of the Company’s first fiscal quarter of 2024 and thereafter. For the Company’s second and third fiscal quarters in 2023, the Third Amendment suspended the fixed charge coverage ratio covenant and added a minimum EBITDA covenant of $ 22.5 million as of the end of each such fiscal quarter. Under the terms of the Third Amendment, the Company and the Lender also agreed to decrease the maximum availability under the senior revolving credit facility from $ 90.0 million to $ 75.0 million, upon the consummation of the sale of the Company’s Mexican subsidiary and the dissolution of Escalade Insurance, Inc. The proceeds from such sale and dissolution, respectively, were used to partially prepay the amounts outstanding under the revolving credit facility. As reflected in the Fourth Amendment to the Restated Credit Agreement effective September 1, 2023, the maximum availability of the senior revolving credit facility was reduced to $ 85.0 million following the dissolution of Escalade Insurance, Inc. On October 11, 2024, the Company entered into the Fifth Amendment (the “Fifth Amendment”) to the Restated Credit Agreement. The Fifth Amendment eliminated the fixed charge coverage ratio covenant and related provisions. The fixed charge ratio covenant was replaced by a new minimum interest coverage ratio covenant of 3.50 to 1:00 effective September 30, 2024. Under the terms of the Fifth Amendment, the Company and the Lender also agreed to decrease the maximum availability under the senior revolving credit facility from $ 75.0 million to $ 60.0 million, but added an accordion feature that could increase the facility in an amount not to exceed $ 85.0 million. The Fifth Amendment further revised the restricted payments covenant to provide that if at any time the Company’s Funded Debt to EBITDA Ratio would exceed 1.75 to 1.0, then the aggregate combined total of cash dividends and Company share repurchases may not exceed $ 12.0 million in any trailing twelve month period. 51 Each loan will bear interest based on the applicable SOFR rate for the interest period in effect plus the Applicable Rate. The Applicable Rate shall be determined as of the end of each quarter based upon Escalade’s Funded Debt to Adjusted Ratio as of the most recent determination date: Funded Debt to EBITDA Ratio Revolving Commitment ABR Spread Revolving Commitment Term Benchmark Spread Letter of Credit Fee Commitment Fee Rate Category 1 Greater than or equal to 2.50 to 1.0 0.25 % 2.00 % 2.00 % 0.30 % Category 2 Greater than or equal to 1.50 to 1.0 but less than 2.50 to 1.0 - 0 - 1.75 % 1.75 % 0.25 % Category 3 Less than 1.50 to 1.0 ( 0.25 %) 1.50 % 1.50 % 0.20 % The Applicable Rate is determined as of the end of each quarter based upon the Company’s annual or quarterly consolidated financial statements and is effective during the period commencing the date of delivery to the agent. The Company’s indebtedness under the 2022 Restated Credit Agreement continues to be collateralized by liens on all of the present and future equity of each of the Company’s and Indian’s domestic subsidiaries and substantially all of the assets of the Company (excluding real estate). Each direct and indirect domestic subsidiary of the Company and Indian has secured its guaranty of indebtedness incurred under the revolving facility with a first priority security interest and lien on all of such subsidiary’s assets. The obligations, guarantees, liens and other interests granted by the Company, Indian, and their domestic subsidiaries continues in full force and effect. The Company was in compliance with the debt covenants set forth in the 2022 Restated Credit Agreement as of December 31, 2024. Long-Term Debt Long-term debt at fiscal year-ends was as follows: In Thousands 2024 2023 Senior secured revolving credit facility of $ 60.0 million with a maturity of January 21, 2027. The interest rate at December 31, 2024 was 7.25 % and 8.54 % at December 31, 2023. $ - $ 18,158 Term loan of $ 50.0 million with a maturity date of January 21, 2027. The interest rate at December 31, 2024 and December 31, 2023, was 2.97 %. 25,595 32,738 25,595 50,896 Current portion of long-term debt ( 7,143 ) (7,143 ) $ 18,452 $ 43,753 The Company makes monthly principal payments under the Term loan of $ 595 thousand. As of December 31, 2024, the Company had $ 52.3 million of availability on its senior secured revolving credit facility. 52 Note 7 — Earnings Per Share The shares used in the computation of the Company’s basic and diluted earnings per common share are as follows: In Thousands 2024 2023 Weighted average common shares outstanding 13,844 13,714 Dilutive effect of stock options and restricted stock units 197 190 Weighted average common shares outstanding, assuming dilution 14,041 13,904 Number of anti-dilutive stock options and unvested restricted stock units - - Weighted average common shares outstanding, assuming dilution, includes the incremental shares that would be issued upon the assumed exercise of stock options outstanding. Note 8 — Employee Benefit Plans The Company has an employee profit-sharing salary reduction plan, pursuant to the provisions of Section 401(k) of the Internal Revenue Code, for all employees. The Company’s contribution is a matching percentage of the employee contribution as determined by the Board of Directors annually. The Company’s expenses for the plan were $ 1.0 million and $ 1.1 million for 2024 and 2023, respectively. Note 9 — Stock Compensation Plans In May 2017, Shareholders approved the Escalade, Incorporated 2017 Incentive Plan (2017 Incentive Plan), which is an incentive plan for key employees, directors and consultants with various equity-based incentives as described in the plan document. The 2017 Incentive Plan is a replacement for the 2007 Incentive Plan, which expired at the end of April 2017. The 2017 Incentive Plan is administered by the Board of Directors or a committee thereof, which is authorized to determine, among other things, the key employees, directors or consultants who will receive awards under the plan, the amount and type of award, exercise prices or performance criteria, if applicable, and vesting schedules. Under the original terms of the plan and subject to various restrictions contained in the plan document, the total number of shares of common stock which may be issued pursuant to awards under the Plan may not exceed 1,661,598 . Restricted Stock Awards In 2024, the Company awarded 12,900 restricted stock units to directors and 130,800 restricted stock units to employees. The restricted stock units awarded to directors time vest over two years (one-half one year from grant date and one-half two years from grant date) provided that the director is still a director of the Company at the vest date. Director restricted stock units are subject to forfeiture, except for termination of services as a result of retirement, death or disability, if on the vesting date the director no longer holds a position with the Company. All of the 2024 restricted stock units awarded to employees time vest over three years (one-third one year from grant, one-third two years from grant and one-third three years from grant) provided that the employee is still employed by the Company on the vesting date. The Company has elected to account for forfeitures when they actually occur. 53 A summary of restricted stock awards activity is as follows: Number of Shares Weighted Average Grant Date Fair Value Non-vested stock units as of December 31, 2022 252,029 $ 14.33 Granted 166,763 12.68 Vested ( 107,031 ) 13.97 Forfeited ( 6,635 ) 13.31 Non-vested stock units as of December 31, 2023 305,126 $ 13.58 Granted 143,700 12.86 Vested ( 140,502 ) 13.91 Forfeited ( 1,002 ) 12.98 Non-vested stock units as of December 31, 2024 307,322 $ 13.09 The closing market price of the Company’s stock on the grant date is used to value restricted stock units. In 2024 and 2023 the Company recognized $ 1.9 million and $ 2.0 million, respectively, in compensation expense related to restricted stock units and as of December 31, 2024 and December 31, 2023, there was $ 1.3 million and $ 1.4 million, respectively, of unrecognized compensation expense related to restricted stock units. The unrecognized compensation expense of unvested restricted stock awards not yet recognized as of December 31, 2024 are expected to be recognized over the weighted average period of 1.35 years. Note 10 — Provision for Taxes Income before taxes and the provision for taxes consisted of the following: In Thousands 2024 2023 Income before taxes: $ 17,776 $ 12,493 Provision (benefit) for taxes: Current Federal $ 3,985 $ 3,472 State 627 583 4,612 4,055 Deferred Federal 188 ( 1,230 ) State ( 10 ) ( 161 ) 178 ( 1,391 ) $ 4,790 $ 2,664 The provision for income taxes was computed based on income before taxes. A reconciliation of the provision for income taxes to the amount computed using the statutory rate follows: In Thousands 2024 2023 Income tax at statutory rate $ 3,733 $ 2,623 Increase (decrease) in income tax resulting from State tax expense, net of federal effect 487 333 Federal true-ups 121 ( 53 ) Federal tax credits ( 158 ) ( 405 ) Sale of Harvard Sports 582 - Captive insurance earnings - ( 112 ) Incentive stock options ( 8 ) 33 Other 33 245 Recorded provision for income taxes $ 4,790 $ 2,664 54 The provision for income taxes was computed based on income before taxes. The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction, and multiple state and foreign jurisdictions. The Company is subject to future examinations by federal, state and other tax authorities for all years after 2020. The Company has state, net of federal benefit, research tax credit carryforwards of $ 322 thousand as of December 31, 2024. The state research tax credit carryforwards begin to expire in 2026. A valuation allowance has been established in the amount of $ 322 thousand as of December 31, 2024 related to the state tax credit carryforwards, leaving an ending deferred, net of federal benefit, in the amount of zero . The increase in the valuation allowance relates to the decrease in the projected tax liability which would be offset by the credit carryforward. The valuation allowance is based on the historical results and estimated future results of the Company, as it is the judgment of management not all of these tax carryforward attributes will be realized before they begin to expire. At December 31, 2024, the Company had domestic federal income taxes receivable of $ 254 thousand, domestic state income taxes receivable of $ 211 thousand, and transition tax payable of $ 297 thousand recorded. At December 31, 2023, the Company had domestic federal income taxes receivable of $ 150 thousand, domestic state income taxes payable of $ 62 thousand, and transition tax payable of $ 387 thousand recorded. The tax effects of temporary differences and carryforwards that give rise to significant portions of the deferred tax assets and deferred tax liabilities at December 31, 2024 and 2023 are as follows: In Thousands 2024 2023 Assets Valuation reserves $ 1,350 $ 1,088 Stock based compensation 217 295 Federal and state credits 322 840 Lease obligation 288 2,090 Other 4 28 Capitalized research costs 2,714 2,104 Total assets 4,895 6,445 Liabilities Property and equipment ( 864 ) ( 1,206 ) Goodwill and intangible assets ( 6,139 ) ( 5,732 ) Lease – right of use asset ( 277 ) ( 1,959 ) Prepaid insurance ( 595 ) ( 354 ) Total liabilities ( 7,875 ) ( 9,251 ) Valuation Allowance Beginning balance ( 319 ) ( 351 ) (Increase) Decrease during period ( 3 ) 32 Ending balance ( 322 ) ( 319 ) $ ( 3,302 ) $ ( 3,125 ) The following table reconciles the total amounts of unrecognized tax benefits: In Thousands 2024 2023 Balance at beginning of year $ - $ 20 Closure of tax years - ( 20 ) Balance at end of year $ - $ - The total amount of unrecognized tax benefits, net of federal income tax benefits, were zero at December 31, 2024 and December 31, 2023. 55 The Company had no accrued interest and penalties related to taxes, recognized as a liability, as of December 31, 2024. The Company has assessed its risk associated with all tax return positions and believes its tax reserve estimate reflects its best estimate of the deductions and positions it will be able to sustain, or it may be willing to concede as part of a settlement. At this time, the Company does not anticipate any change in its tax reserves in the next twelve months. The Company will continue to monitor the progress and conclusion of all audits and will adjust its estimated liability as necessary. Note 11 — Operating Segment and Geographic Information The Company operates as one operating segment. The Company’s chief operating decision maker (“CODM”) is its president and chief executive officer, who reviews financial information presented on a consolidated basis. The CODM uses consolidated net sales and consolidated net income to assess financial performance and allocate resources. Reconciliation to net income: In Thousands 2024 2023 Net Sales Sporting Goods $ 251,510 $ 263,566 Total Net Sales $ 251,510 $ 263,566 Sporting Goods Segment Operating Expenses: Cost of products sold $ 189,306 $ 201,795 Other operating expenses 39,116 44,275 Sporting Goods segment expenses 228,422 246,070 Sporting Goods Segment Operating Income 23,088 17,496 Unallocated corporate (expense) income ( 3,084 ) 315 Total Operating Income $ 20,004 $ 17,811 Consolidated Other Income (Expense): Interest expense ( 2,302 ) ( 5,349 ) Other income 74 31 Total Income Before Income Taxes $ 17,776 $ 12,493 Sporting Goods Segment Provision for Income Taxes 5,732 3,411 Unallocated benefit for taxes ( 942 ) ( 747 ) Total Net Income $ 12,986 $ 9,829 Identifiable Assets Sporting Goods $ 217,941 $ 246,875 Corporate 8,389 6,130 Total Identifiable Assets $ 226,330 $ 253,005 Depreciation and Amortization Sporting Goods $ 6,041 $ 5,671 Unallocated corporate -- -- Total Depreciation and Amortization $ 6,041 $ 5,671 Capital Expenditures Sporting Goods $ 2,038 $ 2,085 Corporate -- -- Total Capital Expenditures $ 2,038 $ 2,085 There were no changes to the composition of segments in 2024. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. 56 The Sporting Goods segment consists of home entertainment products such as table tennis tables and accessories; basketball goals; pickleball; pool tables and accessories; outdoor playsets; water sports; soccer and hockey tables; archery equipment and accessories; and fitness, arcade and darting products. Customers include retailers, dealers and wholesalers located throughout North America, Europe and the rest of the world. All Other consists of general and administrative expenses not specifically related to the operating business segment. The Company had net assets of $ 5.3 million located in Mexico as of December 31, 2023. There were no assets in Mexico as of December 31, 2024. During 2024 and 2023, the Company had one customer that accounted for approximately 19 % and 20 %, respectively, of the Company’s revenues. During 2024 and 2023, the Company had another customer which accounted for approximately 13 % and 11 %, respectively, of the Company’s revenues. As of December 31, 2024 and December 31, 2023, the Company had approximately 25 % and 29 %, respectively, of its total accounts receivable with one customer. As of December 31, 2024, approximately 28 employees of the Company's labor force were covered by a collective bargaining agreement that expired on January 31, 2025. The impact is expected to be immaterial to operations. Net sales are attributed to country based on location of customer. Net sales by geographic region/country were as follows: In Thousands 2024 2023 United States $ 239,472 $ 252,536 Canada 5,579 4,924 Australia 1,669 1,462 Other 4,790 4,644 $ 251,510 $ 263,566 Note 12 — Commitments and Contingencies The Company is involved in litigation arising in the normal course of its business. The Company does not believe that the disposition or ultimate resolution of existing claims or lawsuits will have a material adverse effect on the business or financial condition of the Company. The Company has entered into various agreements whereby it is required to make minimum purchase commitments, royalty and license payments. The Company entered into a non-cancelable minimum purchase agreement during 2024 with a term of three years. The minimum purchases made during the current year related to this agreement were approximately $ 467 thousand. At December 31, 2024, the Company had future estimated minimum non-cancelable purchase commitments, royalty and license payments as follows: In Thousands Amount 2025 $ 2,747 2026 3,103 2027 5,622 2028 641 2029 664 Thereafter - $ 12,777 Note 13 — Fair Values of Financial Instruments Accounting Standard Codification (“ASC”) 820, “Fair Value Measurement and Disclosures,” outlines a valuation framework and creates a fair value hierarchy for assets and liabilities as follows: - Level 1: Observable inputs such as quoted prices in active markets; - Level 2: Inputs other than quoted prices in active markets that are either directly or indirectly observable; and - Level 3: Unobservable inputs for which little or no market data exists, therefore requiring the Company to develop its own assumptions. 57 Due to their short-term nature, the fair value of cash and cash equivalents, accounts receivable, accounts payable and certain other current liabilities approximated their carrying values at December 31, 2024 and December 31, 2023. The Company believes the carrying value of borrowings under our senior secured revolving credit facility, due to variable rate interest, adequately reflects the fair value of these instruments. We measure certain items at fair value on a nonrecurring basis, primarily goodwill, and long-lived tangible and ROU assets, in connection with periodic evaluations for potential impairment. We estimate the fair value of these assets using primarily unobservable inputs and, as such, these are considered Level 3 fair value measurements. The Company discloses the fair value of its term loan using Level 2 inputs, which are estimated using treasury rates for a similar instrument, as follows: December 31, 2024 December 31, 2023 In thousands Carrying Value Fair Value Carrying Value Fair Value Term Loan Facility $ 25,595 $ 23,528 $ 32,738 $ 29,439 Note 14 — Revenue from Contracts with Customers Revenue Recognition – Revenue is recognized when a contract exists with a customer that specifies the goods to be provided at an agreed upon sales price and when the performance obligations under the terms of the contract are satisfied; generally this occurs with the transfer of control of our goods at a point in time based on shipping terms and transfer of control. Sales are made on normal and customary short-term credit terms or upon delivery of point-of-sale transactions. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods. Sales, value add, and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. Shipping and handling fees charged to customers are reported within revenue. The Company enters into contractual arrangements with customers in the form of customer orders that specify goods, quantity, pricing, and associated order terms. The Company does not have long-term contracts that are satisfied over time. Due to the nature of the contracts, no significant judgment exists in relation to the identification of the customer contract, satisfaction of the performance obligations, or transaction price. The Company expenses incremental costs of obtaining a contract due to the short-term nature of the contracts. Gross-to-net sales adjustments – We recognize revenue net of various sales adjustments to arrive at net sales as reported on the statement of operations. These adjustments are referred to as gross-to-net sales adjustments and primarily fall into one of three categories; returns, warranties and customer allowances. Returns – The Company records an accrued liability and reduction in sales for estimated product returns based upon historical experience. An accrued liability and reduction in sales is also recorded for approved return authorizations that have been communicated by the customer. Warranties – Limited warranties are provided on certain products for varying periods. We record an accrued liability and reduction in sales for estimated future warranty claims based upon historical experience and management’s estimate of the level of future claims. Changes in the estimated amounts recognized in prior years are recorded as an adjustment to the accrued liability and sales in the current year. Customer Allowances – Customer allowances are common practice in the industry in which the Company operates. These agreements are typically in the form of advertising subsidies, volume rebates and catalog allowances and are accounted for as a reduction to gross sales. The Company reviews such allowances on an ongoing basis and adjusts, if necessary, as additional information becomes available. 58 Contract Balances – Amounts relating to returns and customer allowances create contract liabilities. Contract balances from contracts with customers are as follows: In Thousands 2024 2023 Customer co-op and volume allowances $ 1,543 $ 1,671 Other customer allowances 1,898 1,457 Customer returns and defectives accrual 3,267 2,197 January 1, 2023 balances for customer co-op and volume allowances, other customer allowances, and customer returns and defectives accrual were $ 1.6 million, $ 2.1 million, and $ 2.2 million, respectively. There are no revenues recognized in 2024 on performance obligations entered into in 2023. As of December 31, 2024, there were no unperformed performance obligations. Contract assets consist of accounts receivables and the January 1, 2023 balance was $ 57.4 million, net of allowance for credit losses. Disaggregation of Revenue – We generate revenue from the sale of widely recognized sporting goods brands in basketball goals, archery, indoor and outdoor game recreation and fitness products. These products are sold through multiple sales channels that include: mass merchants, specialty dealers, key on-line retailers (“E-commerce”) and international. The following table depicts the disaggregation of revenue according to sales channel: Years Ended In Thousands December 31, 2024 December 31, 2023 Gross Sales by Channel: Mass Merchants $ 91,720 $ 88,991 Specialty Dealers 81,076 85,713 E-commerce 94,675 101,964 International 13,114 12,011 Other 3,371 3,975 Total Gross Sales 283,956 292,654 Less: Gross-to-Net Sales Adjustments Returns 8,665 8,426 Warranties 1,690 528 Customer Allowances 22,091 20,134 Total Gross-to-Net Sales Adjustments 32,446 29,088 Total Net Sales 251,510 263,566 Note 15 — Subsequent Events On February 6, 2025, the Board of Directors (the “Board”) of Escalade, Incorporated announced that Armin Boehm has agreed to become the Company’s new Chief Executive Officer and President. Mr. Boehm is expected to commence his employment with Escalade on or about April 1, 2025. Mr. Boehm has no family relationship with any other executive officer or director of Escalade. Mr. Boehm has not been involved in any related party transaction with Escalade. 59 Signatures Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ESCALADE, INCORPORATED By: /s/ Walter P. Glazer, Jr. March 10, 2025 Walter P. Glazer, Jr. President and Chief Executive Officer Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated. /s/ Walter P. Glazer, Jr. Walter P. Glazer, Jr. Chairman and Director and President and Chief Executive Officer March 10, 2025 /s/ Katherine F. Franklin Director March 10, 2025 Katherine F. Franklin /s/ Edward E. Williams Director March 10, 2025 Edward E. Williams /s/ Richard Baalmann, Jr. Director March 10, 2025 Richard Baalmann, Jr. /s/ Patrick Griffin Patrick Griffin Director March 10, 2025 /s/ Stephen R. Wawrin Stephen R. Wawrin Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) March 10, 2025 60